Arena Pharmaceuticals Inc Stock

Description Arena Pharma

Arena Pharmaceuticals Inc, with the stock symbol ARNA, is a US-based biopharmaceutical company that develops drugs for various therapeutic areas including cardiovascular diseases, metabolic diseases, inflammatory diseases, and central nervous system disorders. Arena Pharma's lead product is Belviq, a weight-loss drug that was approved by the US Food and Drug Administration (FDA) in 2012. Additionally, the company is focused on developing drugs for the treatment of various diseases, including pulmonary arterial hypertension, ulcerative colitis, and autoimmune disease. Arena Pharma has partnerships with several major pharmaceutical companies, including Eisai Co Ltd., United Therapeutics Corp., and Boehringer Ingelheim International GmbH. As of August 2021, the company had a market capitalization of approximately $1.28 billion.

Competitors of Arena Pharma

Arena Pharma faces competition from multiple companies, each with their respective strengths and weaknesses in the biotechnology and pharmaceutical industry. The following are some of the most important competitors of Arena Pharma:

1. Amgen Inc. (AMGN): Amgen is a leading biotech company that develops innovative medicines for serious illnesses. It is a global leader in biotechnology with a strong pipeline of products that targets oncology, cardiovascular, and inflammatory diseases.

2. Biogen Inc. (BIIB): Biogen is a leading biotech company that engages in discovering, developing, and delivering innovative therapies for people living with serious neurological and neurodegenerative diseases. Its products are focused on multiple sclerosis, spinal muscular atrophy, Alzheimer's disease, and other neurology disorders.

3. Gilead Sciences Inc. (GILD): Gilead is a leading biopharmaceutical company with a portfolio of more than twenty-five products in various therapeutic areas, including liver diseases, HIV/AIDS, oncology, inflammation, and respiratory diseases.

4. Insys Therapeutics Inc. (INSY): Insys Therapeutics is a specialty pharmaceutical company that focuses on developing and commercializing innovative products that address unmet needs in pain management and other areas. It markets a range of products that includes Subsys, Naloxone injection, and Syndros.

5. Pfizer Inc. (PFE): Pfizer is one of the largest pharmaceutical companies in the world with a broad portfolio of products that includes human and animal biologic and small molecule medicines and vaccines. Its products are focused on oncology, immunology, cardiology, and neurology.

Overall, competition in the biotech and pharmaceutical industry is intense, and Arena Pharma must continue to innovate, develop new therapies, and expand its product portfolio to remain competitive.